Olimel N12e (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

The amino acids in Olimel N12e are directly delivered into the bloodstream, where they become available for protein synthesis, nitrogen balance, and energy metabolism. By replenishing essential amino acid pools, the solution helps maintain lean body mass, supports wound healing, and sustains immune function during periods of nutritional deprivation.

The dose of Olimel N12e is individualized by the prescribing clinician based on the patient’s weight, metabolic needs, renal and hepatic function, and overall nutritional plan. Healthcare professionals calculate the appropriate volume and rate of infusion to meet the patient’s specific amino acid requirements.

Safety data for Olimel N12e in pregnancy and lactation are limited. The product should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To order Olimel N12e, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if needed), and necessary import documentation.

Olimel N12e offers a comprehensive profile of ten essential amino acids in a single sterile solution, matching or exceeding the amino acid composition of many standard parenteral nutrition formulations. Its EU‑origin manufacturing and GDP compliance provide assurance of quality, while the specific blend may differ from competitor products that use alternative ratios or additional non‑essential amino acids.

Olimel N12e must be stored at 2‑8 °C, protected from light, and kept in its original container. Do not freeze or shake the solution. Before use, inspect the vial for particulate matter or discoloration and allow it to reach room temperature if required for infusion.

The product is administered intravenously as a sterile solution. It is typically infused through a dedicated catheter or central line, with the rate and volume determined by the prescribing clinician based on the patient’s nutritional prescription and clinical status.

Serious risks include severe hypersensitivity reactions such as anaphylaxis, hyperammonemia in patients with liver dysfunction, and acute renal impairment in susceptible individuals. Monitoring for signs of allergic reaction, metabolic disturbances, and renal function is essential during therapy.

Olimel N12e should be avoided in patients with known hypersensitivity to any of its amino acid components, those with uncontrolled severe electrolyte imbalances, or individuals with acute renal or hepatic failure where the risk of nitrogen overload outweighs benefit. Clinical judgment is required for each case.